Activated cholesterol metabolism is integral for innate macrophage responses by amplifying Myd88 signaling.
Activated cholesterol metabolism is integral for innate macrophage responses by amplifying Myd88 signaling.
复制标题
DOI:
10.1172/jci.insight.138539
复制
发表时间:
2022-11-22
期刊:
影响因子:
8
通讯作者:
Oishi, Yumiko
中科院分区:
文献类型:
--
作者:
Hayakawa, Sumio;Tamura, Atsushi;Nikiforov, Nikita;Koike, Hiroyuki;Kudo, Fujimi;Cheng, Yinglan;Miyazaki, Takuro;Kubekina, Marina;Kirichenko, Tatiana, V;Orekhov, Alexander N.;Yui, Nobuhiko;Manabe, Ichiro;Oishi, Yumiko
Recent studies have shown that cellular metabolism is tightly linked to the regulation of immune cells. Here, we show that activation of cholesterol metabolism, involving cholesterol uptake, synthesis, and autophagy/lipophagy, is integral to innate immune responses in macrophages. In particular, cholesterol accumulation within endosomes and lysosomes is a hallmark of the cellular cholesterol dynamics elicited by Toll-like receptor 4 activation and is required for amplification of myeloid differentiation primary response 88 (Myd88) signaling. Mechanistically, Myd88 binds cholesterol via its CLR recognition/interaction amino acid consensus domain, which promotes the protein’s self-oligomerization. Moreover, a novel supramolecular compound, polyrotaxane (PRX), inhibited Myd88‑dependent inflammatory macrophage activation by decreasing endolysosomal cholesterol via promotion of cholesterol trafficking and efflux. PRX activated liver X receptor, which led to upregulation of ATP binding cassette transporter A1, thereby promoting cholesterol efflux. PRX also inhibited atherogenesis in Ldlr–/– mice. In humans, cholesterol levels in circulating monocytes correlated positively with the severity of atherosclerosis. These findings demonstrate that dynamic changes in cholesterol metabolism are mechanistically linked to Myd88‑dependent inflammatory programs in macrophages and support the notion that cellular cholesterol metabolism is integral to innate activation of macrophages and is a potential therapeutic and diagnostic target for inflammatory diseases.
登录
查看更多内容
影响因子:
3.4
作者:
Guo M;Härtlova A;Dill BD;Prescott AR;Gierliński M;Trost M
通讯作者:
Trost M
影响因子:
12.6
作者:
Hu YB;Dammer EB;Ren RJ;Wang G
通讯作者:
Wang G
DOI:
10.1161/atvbaha.108.179705
发表时间:
2012-09
期刊:
Arteriosclerosis, thrombosis, and vascular biology
影响因子:
--
作者:
Libby P
通讯作者:
Libby P
影响因子:
7.7
作者:
Ito A;Hong C;Rong X;Zhu X;Tarling EJ;Hedde PN;Gratton E;Parks J;Tontonoz P
通讯作者:
Tontonoz P
DOI:
10.1016/s0005-2760(98)00178-7
发表时间:
1999-01-29
影响因子:
4.8
作者:
Avdulov, NA;Chochina, SV;Wood, WG
通讯作者:
Wood, WG